Biosenta Inc. announced a significant milestone in its technological and operational advancements with the successful construction and operation of a bench scale production plant. The results from this production not only surpassed expectations, but also showcased that patented Tri-Filler antimicrobial technology is ready for accelerated development and scaling towards industrial manufacturing applications. operational Success and Optimizations.

Biosenta has successfully constructed and commenced operations of a bench scale production plant, showcasing capability to produce up to 15 kilograms of Tri-Filler daily. This marks a significant scale-up from previous capacity, which was limited to smaller quantities for lab testing purposes only.